Biobizkaia
Forschungszentrum
University of L'Aquila
L'Aquila, ItaliaPublikationen in Zusammenarbeit mit Forschern von University of L'Aquila (15)
2024
-
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic
Journal of Neurology, Vol. 271, Núm. 9, pp. 5813-5824
-
Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry
Ophthalmology and Therapy, Vol. 13, Núm. 3, pp. 761-774
-
Effectiveness of Disease-Modifying Treatment on Spinal Cord Lesion Formation in Relapse-Onset Multiple Sclerosis: An MSBase Registry Study
CNS Drugs, Vol. 38, Núm. 11, pp. 921-930
-
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders
Ocular Immunology and Inflammation
-
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry
Seminars in Arthritis and Rheumatism, Vol. 66
-
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study
Journal of Neurology, Neurosurgery and Psychiatry
-
Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study
Journal of Neurology, Neurosurgery and Psychiatry
2023
2022
-
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity
Human Genetics, Vol. 141, Núm. 1, pp. 147-173
2021
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2018
-
Improving adherence to gout therapy: An expert review
Therapeutics and Clinical Risk Management, Vol. 14, pp. 793-802
2016
1995
-
Biotype diversity of candida parapsilosis and its relationship to the clinical source and experimental pathogenicity
Journal of Infectious Diseases, Vol. 171, Núm. 4, pp. 967-975